Key Findings:  Cannabidiol (CBD) may represent a very promising agent with the highest prospect for therapeutic use in the treatment of neurodegenerative illness.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Italy
Year of Pub:  2009
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III